Utilization of the HTSCA and CFU-C assay to identify two new 2-chloroethylnitrosourea congeners of amino acid amides with increased in vitro activity against human glioma compared with BCNU-Reference-Cited by-同舟云学术

Utilization of the HTSCA and CFU-C assay to identify two new 2-chloroethylnitrosourea congeners of amino acid amides with increased in vitro activity against human glioma compared with BCNU

Published:1985-03 Issue:2 Volume:14 Page:156-159
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother. Pharmacol.

Author:

Panasci Lawrence C.,Dufour Maurice,Chevalier Lina,Isabel Guy,Lazarus Philip,McQuillan Angela,Arbit Ehud,Brem Steven,Feindel William

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/BF00434356.pdf

Reference23 articles.

1. Carter SK (1973) An overview of the status of the nitrosoureas in other tumors. Cancer Chemother Rep 4: 35?46

2. Chabner BA, Myers CE, Oliverio VT (1977) Clinical pharmacology of anticancer drugs. Sem Oncol 4: 165?190

3. Christensen HN (1969) Some special kinetic problems of transport. Adv Enzymol 32: 1?20

4. Hamburger AW, Salmon SE (1977) Primary bioassay of human myeloma stem cells. J Clin Invest 60: 846?854

5. Hamburger AW, White CP, Tencer K (1982) Effect of enzymatic disaggregation on proliferation of human tumor cells in soft agar. JNCI 68: 945?949

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SarCNU mediates selection of P140K methylguanine-DNA-methyltransferase transduced human CD34+ cells in vitro;Blood Cells, Molecules, and Diseases;2003-07

2. SarCNU, a Nitrosourea Analog on a Day 1, 5, and 9 Oral Schedule: A Phase I and Pharmacokinetic Study in Patients With Advanced Solid Tumors;Journal of Clinical Oncology;2003-01-15

3. Plasma pharmacokinetics and bioavailability of 1-(2-chloroethyl)-3-sarcosinamide-1-nitrosourea after intravenous and oral administration to mice and dogs;Cancer Chemotherapy and Pharmacology;2001-09-01

4. Antitumor efficacy of SarCNU in a human glioma xenograft model expressing both MGMT and extraneuronal monoamine transporter;Journal of Neuro-Oncology;2001

5. Chemosensitivity of glioma cells in vitro: a meta analysis;Journal of Cancer Research and Clinical Oncology;1999-08-06